Table 1.
Different treatment groups in mice.
| Group | Treatment | Duration |
|---|---|---|
| NC | Normal saline (gavage) | Days 1–14 |
| MC | 80 mg/kg.bw CTX (inject) | Days 10, 12 and 14 |
| MSCP-L | 100 mg/kg/d MSCP (gavage) | Days 1–14 |
| 80 mg/kg.bw CTX (inject) | Days 10, 12 and 14 | |
| MSCP-M | 200 mg/kg/d MSCP (gavage) | Days 1–14 |
| 80 mg/kg.bw CTX (inject) | Days 10, 12 and 14 | |
| MSCP-H | 400 mg/kg/d MSCP (gavage) | Days 1–14 |
| 80 mg/kg.bw CTX (inject) | Days 10, 12 and 14 | |
| AMP | 400 mg/kg/d AMP (gavage) | Days 1–14 |
| 80 mg/kg.bw CTX (inject) | Days 10, 12 and 14 |
NC, normal control; MC, cyclophosphamide; MSCP-L, pretreatment-low dose group with 100 mg/kg/d MSCP; MSCP-M, pretreatment-middle dose group with 200 mg/kg/d MSCP; MSCP-H, pretreatment-high dose group with 400 mg/kg/d MSCP; AMP, pretreatment with 400 mg/kg/d AMP.